russ2000_2_0469|OSMT|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_2_0469|OSMT|1|Osmotica Pharmaceuticals PLC Total Current Assets (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Cash and Short Term Investments (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Inventories (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Net PP&E (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Goodwill and Intangibles (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Total Liabilities (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Total Current Liabilities (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Total Long Term Liabilities (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Total Deposits (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Book Value (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Retained Earnings (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Treasury Stock (Quarterly) (USD)|Osmotica Pharmaceuticals PLC EV to Revenues|Osmotica Pharmaceuticals PLC EV to Earnings|Osmotica Pharmaceuticals PLC EV to Free Cash Flow|Osmotica Pharmaceuticals PLC EV to Assets (Quarterly)|Osmotica Pharmaceuticals PLC PS Ratio|Osmotica Pharmaceuticals PLC PE Ratio|Osmotica Pharmaceuticals PLC Price to Book Value|Osmotica Pharmaceuticals PLC PEG Ratio|Osmotica Pharmaceuticals PLC Debt to Equity Ratio|Osmotica Pharmaceuticals PLC Dividend Yield|Osmotica Pharmaceuticals PLC Shareholder Yield (TTM)|Osmotica Pharmaceuticals PLC Percent of Shares Outstanding Short|Osmotica Pharmaceuticals PLC Total Receivables (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Total Payables (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Total Capital Stock (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Return on Invested Capital|Osmotica Pharmaceuticals PLC Quality Ratio Score|Osmotica Pharmaceuticals PLC Momentum Score|Osmotica Pharmaceuticals PLC Beta (1Y)|Osmotica Pharmaceuticals PLC Sustainable Growth Rate (TTM)|Osmotica Pharmaceuticals PLC Institutional Investor Ownership Percentage|Osmotica Pharmaceuticals PLC Average Diluted Shares Outstanding (Quarterly)|Osmotica Pharmaceuticals PLC Total Employees (Annual)|Osmotica Pharmaceuticals PLC EPS Diluted (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Shares Outstanding|Osmotica Pharmaceuticals PLC Repurchase of Capital Stock (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Ordinary Shares Number (Quarterly)|Osmotica Pharmaceuticals PLC Payout Ratio|Osmotica Pharmaceuticals PLC Quick Ratio (Quarterly)|Osmotica Pharmaceuticals PLC Normalized Diluted EPS (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Stock Buybacks (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Effective Tax Rate (TTM)|Osmotica Pharmaceuticals PLC Return on Equity|Osmotica Pharmaceuticals PLC Net Income (TTM) (USD)|Osmotica Pharmaceuticals PLC Revenue (TTM) (USD)|Osmotica Pharmaceuticals PLC Dividend Per Share (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Revenue (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Gross Profit (Quarterly) (USD)|Osmotica Pharmaceuticals PLC SG&A Expense (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Pre-Tax Income (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Net Income (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Net Interest Income (Quarterly) (USD)|Osmotica Pharmaceuticals PLC Price (USD)|Osmotica Pharmaceuticals PLC Total Return Price (USD)|Osmotica Pharmaceuticals PLC Enterprise Value (USD)|Osmotica Pharmaceuticals PLC 30-Day Average Daily Volume|Osmotica Pharmaceuticals PLC 1 Year Price Returns (Daily)||
russ2000_2_0469|OSMT|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_2_0469|OSMT|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
russ2000_2_0469|OSMT|5|101.333333333|101.333333333|101.333333333|101.333333333|101.333333333|101.333333333|101.333333333|101.333333333||101.333333333|101.333333333||1.44597249509|91.1666666667|1.43913043478|91.1666666667|1.44597249509||1.44597249509|1.45019920319|91.2|1.4516765286|91.1666666667|15.2173913043|101.333333333|101.333333333|101.333333333|91.2857142857|91.2857142857|30.5|30.4545454545|91.2857142857|30.5|91.2727272727|243.333333333|91.2727272727|30.8636363636|91.2857142857|101.333333333|91.375|91.2|91.2727272727|91.2857142857|91.375|91.2857142857|91.375|91.375||91.2727272727|91.2727272727|91.2727272727|91.2727272727|91.2727272727|91.2727272727|1.4516765286|1.4516765286|1.44597249509|1.45188284519|1.44921875||
russ2000_2_0469|OSMT|6|9|9|9|9|9|9|9|9||9|9||509|6|460|6|509||509|251|10|507|6|46|9|9|9|7|7|10|11|7|14|11|3|11|22|7|9|8|10|11|7|8|7|8|8||11|11|11|11|11|11|507|507|509|478|256||
russ2000_2_0469|OSMT|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
russ2000_2_0469|OSMT|201709||||||||||||||||||||||||||||||||||45.8598||-0.2864||||||0.1347|||||||53.7412|32.2769|13.2586|-24.3197|-12.2728|-7.301|||||||
russ2000_2_0469|OSMT|201712|114.8261|34.7432|16.9469|31.4101|772.5615|483.9564|124.6762|359.2802||435.7838|||||||||||0.7357||||37.638|36.0699||||||||45.8598|414|0.026|||51.1571||0.5806|0.033|||||||76.3323|28.5078|15.654|-26.5244|1.1907|-7.3318|||||||
russ2000_2_0469|OSMT|201803||||||||||||||||||||||||||||||||||45.8598||-0.1075||||||-0.1005|||||||59.8008|26.2392|17.162|-5.8027|-4.6073|-4.843|||||||
russ2000_2_0469|OSMT|201806|126.2613|28.4082|26.0257|31.6622|699.5296|438.7084|112.8704|325.8381||419.5921|||||||||||0.758||||60.9678|32.5568||||||||51.1571|414|0.1151|||51.1571||0.7918|0.1151||79.9724||-9.8014|261.7332||71.8589|38.1824|16.6759|7.7075|5.8881|-5.2414|||||||
russ2000_2_0469|OSMT|201809|149.3167|32.2025|25.5939|31.3015|674.0545|439.9693|115.6142|324.3551||415.5031|||2.6686||||1.5383||1.0788||0.7607|||0.0799|72.7183|27.8609||-0.153|3|||-0.2679||51.1571||-0.0705|51.5214||51.1571||0.9075|0.0176||96.4645|-0.2679|-1.1348|274.3369||66.3448|32.9886|17.4517|-7.4783|-3.6063|-5.3113|8.7|8.7|732.1083|58964.3||7.88|
russ2000_2_0469|OSMT|201812|172.364|70.834|24.383|31.263|591.245|411.777|114.001|297.776||383.847|-102.12||2.2934|-5.5315|18.0991|0.7601|1.4746||1.0604||0.6997||-13.1972|0.3187|56.424|24.871|0.525|-15.1953|4|||-26.4289||52.5189|466|-2.0375|52.5189||52.5189||1.1163|-0.271|-58.084|7.8648|-26.4289|-109.3313|263.701||65.6964|28.1097|22.9534|-113.0906|-107.0058|-5.3943|7.75|7.75|604.7645|104297.7333||7.84|7.19
russ2000_2_0469|OSMT|201903|163.962|63.0617|27.8148|37.1029|574.3764|394.9089|96.4923|298.4166||381.2377|-108.56||1.509|-3.5354|18.7677|0.5075|0.7149||0.5538||0.7026||5.5779|0.2812|56.8865|21.0868|0.5252|-16.0839|4|||-27.3607||52.5189||-0.13|52.5189||52.5189||1.2431|-0.13||7.3909|-27.3607|-111.4109|261.0261||57.126|27.923|21.656|-7.441|-6.687|-4.501|3.6|3.6|393.881|53342.5333||4.02|2.4
russ2000_2_0469|OSMT|201906|173.9748|63.737|27.8753|37.4598|431.7427|385.9246|97.9039|288.0207||257.9107|-233.214||1.6384|-1.6691|13.7484|0.6278|0.8037||0.6638|-0.0004|1.0405||-55.9976|0.5119|68.1424|19.0509|0.5252|-36.7254|4|||-65.1658|6.1801|52.5189||-2.38|52.5189||52.5189||1.347|-0.1864||8.3828|-65.1658|-242.168|246.6992||57.532|24.888|25.511|-136.316|-124.869|-4.552|3.8|3.8|404.1919|133536.5||3.26|3.06
russ2000_2_0469|OSMT|201909|167.3022|98.0144|27.24|35.8834|290.1789|352.4764|78.5908|273.8856||141.6968|-346.3799||1.5066|-1.0543|6.2715|0.7494|0.8203||1.4136|-0.0001|1.8918||-23.3391|0.308|33.862|9.9052|0.5216|-59.1529|4|2|2.5977|-111.1465|1.8999|52.4765||-2.15|52.1634|-1.3384|52.1634||1.678|0.011|1.3384|8.5661|-111.1465|-351.2663|245.8156||65.4612|38.1489|24.7512|-127.3275|-112.7046|-4.5036|3.84|3.84|370.3522|109825.5333|-49.0805|4.43|6.685
russ2000_2_0469|OSMT|201912|172.63|95.865|21.305|35.221|254.841|348.547|75.937|272.61||114.708|-373.021||2.2267|-1.973|18.0998|1.1538|1.525||3.1593|-0.0093|2.3359||3.4249|1.8054|43.914|8.495|0.518|-51.6944|5|4|4.9465|-105.8704|9.8626|51.9562|379|-0.51|51.8457|-1.4486|51.8457||1.8407|0.0585|1.4486|9.1003|-105.8704|-270.9012|240.0303||59.9111|37.4407|21.1107|-26.9378|-26.6406|-4.6552|6.99|6.99|534.4864|263303.0667|-9.8065|6.44|5.83
russ2000_2_0469|OSMT|202003|189.664|125.83|20.536|34.458|250.479|331.394|58.154|273.24||143.74|-376.104||1.4239|-1.2335|9.3459|0.6939|0.7389||1.303|-0.0045|1.8661||-15.3599|2.2855|32.644|8.784|0.589|-56.1603|5|4|4.5683|-128.5957|14.1252|58.2572||-0.05|58.8987|-0.167|58.8987||2.7251|-0.05|-31.624|8.6801|-128.5957|-267.2972|231.5533||48.649|28.059|21.176|-2.123|-3.083|-4.064|3.18|3.18|329.7039|216501.8|-11.6667|4|5.97
russ2000_2_0469|OSMT|202006|186.792|140.376|20.301|32.939|242.498|331.786|58.89|272.896||130.911|-389.103||2.4751|-3.3688|10.3989|1.1316|1.762||3.0208|-0.0096|2.0512||-7.0924|1.4775|17.024|8.798|0.588|-36.4837|6|10|3.2338|-98.5005|14.6084|58.8635||-0.22|58.7607|-0.919|58.7607||2.6728|-0.1751|0.919|8.1368|-98.5005|-155.4272|211.5533||37.532|17.537|16.555|-12.806|-12.999|-3.74|6.73|6.73|523.6055|435281.2333|77.1053|5.35|5.94
russ2000_2_0469|OSMT|202009|||||||||||||2.2369||9.3981||1.4164||2.6359|||||3.0663||||||9|2.6356||13.6273||||||||||||||||||||||5.41|5.41|473.2137|333700.3667|40.8854|5.94|